<rst>
<header>
	<relations>
			<rel name="elaboration" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="purpose" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="evidence" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
			<rel name="contrast" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">6.</segment>
<segment id="2" parent="1001" relname="joint">What do the Clinical Data Teach Us ?</segment>
<segment id="3" parent="1001" relname="joint">As discussed above , the great majority of the radiobiological investigations have been done with very radioresistant and hyper-radiosensitive cells .</segment>
<segment id="4" parent="1001" relname="joint">However , the hyper-radiosensitive and hyper-radioresistant cellular models are not representative of the clinical reality .</segment>
<segment id="5" parent="1006" relname="span">For example , there is no known human genetic syndromes</segment>
<segment id="6" parent="5" relname="elaboration">caused by mutations of Ku or DNA-PKcs proteins , the major NHEJ actors .</segment>
<segment id="7" parent="1008" relname="span">The only human case of gross defect in NHEJ function to non-viability was caused by mutations of DNA ligase IV</segment>
<segment id="8" parent="7" relname="elaboration">( LIG4 ) .</segment>
<segment id="9" parent="1009" relname="span">The majority of cases of fatal post-radiotherapy events were encountered</segment>
<segment id="10" parent="1011" relname="span">after whole-body irradiation of children with ataxia telangiectasia</segment>
<segment id="11" parent="10" relname="restatement">( AT )</segment>
<segment id="12" parent="1011" relname="elaboration">caused by homozygous ATM mutations during their anti-leukemia or lymphoma treatment .</segment>
<segment id="13" parent="14" relname="attribution">It is important to note</segment>
<segment id="14" parent="1013" relname="span">that AT frequency is of about 1/100,000 .</segment>
<segment id="15" parent="1015" relname="span">By contrast , about 5 % – 20 % cancer of patients</segment>
<segment id="16" parent="1016" relname="span">treated by radiotherapy exhibit post-radiotherapy tissue reactions</segment>
<segment id="17" parent="16" relname="elaboration">that can be considered as moderate radiosensitivity .</segment>
<segment id="18" parent="1001" relname="joint">Surprisingly , no or very few rodent cells with moderate radiosensitivity have been the subject of a published radiobiological characterization .</segment>
<segment id="19" parent="1022" relname="span">Interestingly , some of the proteins</segment>
<segment id="20" parent="19" relname="elaboration">whose mutations are responsible for these syndromes</segment>
<segment id="21" parent="1021" relname="same_unit">were cited as components of the different variants of A-NHEJ</segment>
<segment id="22" parent="1021" relname="elaboration">( see Section 4 ) .</segment>
<segment id="23" parent="1026" relname="span">In addition , some genetic syndromes ,</segment>
<segment id="24" parent="23" relname="elaboration">associated or not with cancer proneness , different from the precited ones ,</segment>
<segment id="25" parent="26" relname="preparation">also show a moderate radiosensitivity :</segment>
<segment id="26" parent="1027" relname="span">this is notably the case of neurofibromatosis , Huntington ’s chorea , and tuberous sclerosis syndromes .</segment>
<segment id="27" parent="1029" relname="attribution">It must be stressed</segment>
<segment id="28" parent="1029" relname="span">that these syndromes are caused by mutations of cytoplasmic proteins ,</segment>
<segment id="29" parent="1030" relname="span">which may contradict the historical hypothesis</segment>
<segment id="30" parent="1031" relname="span">that nucleus is the most radiosensitive part of the cell</segment>
<segment id="31" parent="30" relname="elaboration">( see the Introduction ) .</segment>
<segment id="32" parent="1032" relname="span">Furthermore , it also contradicts the hypothesis</segment>
<segment id="33" parent="32" relname="elaboration">that defect of DSB repair is the unique cause of cellular radiosensitivity .</segment>
<segment id="34" parent="1035" relname="span">The question</segment>
<segment id="35" parent="1036" relname="span">of how to build a unified model</segment>
<segment id="36" parent="1038" relname="span">that would describe both hyper-radiosensitivity</segment>
<segment id="37" parent="36" relname="elaboration">observed in LIG4 - and ATM -mutated cells and moderate radiosensitivity</segment>
<segment id="38" parent="1037" relname="same_unit">caused by impairment of alternative signaling and DSB repair pathways remains .</segment>
<segment id="39" parent="1039" relname="span">To date , the ATM protein has been considered as an early actor of the DSB recognition via its phosphorylation of H2AX and the individual radiation response .</segment>
<segment id="40" parent="1041" relname="span">Surprisingly , ATM has not been integrated in all the DSB repair models</segment>
<segment id="41" parent="40" relname="elaboration">discussed above</segment>
<segment id="42" parent="1043" relname="span">while mutations of RAD51 and RAD52</segment>
<segment id="43" parent="42" relname="restatement">( for HR )</segment>
<segment id="44" parent="1045" relname="span">and Ku and DNA-PKcs</segment>
<segment id="45" parent="44" relname="elaboration">( for NHEJ )</segment>
<segment id="46" parent="1044" relname="same_unit">do not cause any viable syndromes in humans (</segment>
<segment id="47" parent="1047" relname="preparation">Figure 1</segment>
<segment id="48" parent="1048" relname="preparation">) .</segment>
<segment id="49" parent="1051" relname="span">Recently , the delay in the radiation-induced nucleo-shuttling of ATM protein</segment>
<segment id="50" parent="49" relname="elaboration">( RIANS )</segment>
<segment id="51" parent="1050" relname="same_unit">was shown to be a reliable parameter</segment>
<segment id="52" parent="1052" relname="joint">for predicting radiosensitivity</segment>
<segment id="53" parent="1052" relname="joint">and to provide a biologically relevant interpretation of the linear-quadratic model , the mathematical basis of the cellular radiation response .</segment>
<segment id="54" parent="1054" relname="span">In the context of the RIANS model , the following mechanistic hypothesis has been proposed :</segment>
<segment id="55" parent="54" relname="circumstance">after irradiation , cytoplasmic trans-auto-phosphorylated dimeric forms of ATM become monomeric and diffuse to the nucleus .</segment>
<segment id="56" parent="1056" relname="span">In the nucleus , active ATM monomers phosphorylate H2AX molecules at DSB sites ,</segment>
<segment id="57" parent="56" relname="elaboration">which activates NHEJ .</segment>
<segment id="58" parent="1057" relname="joint">The ATM monomers will re-dimerize during the DSB repair process .</segment>
<segment id="59" parent="1059" relname="span">Once in nucleus , ATM may also inhibit MRE11 nuclease activity or any other actor</segment>
<segment id="60" parent="59" relname="elaboration">responsible for genomic instability .</segment>
<segment id="61" parent="1062" relname="span">By contrast , in cells with moderate radiosensitivity , over-expressed ATM substrates may delay the RIANS ,</segment>
<segment id="62" parent="61" relname="elaboration">thereby favoring cancer proneness and aging .</segment>
<segment id="63" parent="1063" relname="span">This is notably the case for huntingtin , neurofibromin , and tuberin .</segment>
<segment id="64" parent="63" relname="evidence">(</segment>
<segment id="65" parent="1065" relname="preparation">Figure 6</segment>
<segment id="66" parent="1065" relname="joint">) .</segment>
<segment id="67" parent="1067" relname="preparation">Three groups of radiosensitivity have been defined :</segment>
<segment id="68" parent="1069" relname="span">Group I</segment>
<segment id="69" parent="68" relname="elaboration">( about 75 % to 85 % whole population )</segment>
<segment id="70" parent="1070" relname="span">represents the normosensitive</segment>
<segment id="71" parent="70" relname="restatement">( radioresistant )</segment>
<segment id="72" parent="1072" relname="preparation">patients with a rapid RIANS after 2 Gy , a low risk of post-radiotherapy tissue reaction and of cancer</segment>
<segment id="73" parent="1074" relname="span">Group II</segment>
<segment id="74" parent="73" relname="elaboration">( about 5 – 20 % of whole population )</segment>
<segment id="75" parent="1075" relname="span">represents the patients</segment>
<segment id="76" parent="1076" relname="joint">who elicit a moderate radiosensitivity with a delay in the RIANS</segment>
<segment id="77" parent="1076" relname="joint">due to the sequestration of ATM by mutated and over-expressed substrates .</segment>
<segment id="78" parent="1072" relname="joint">These patients are moderately radiosensitive</segment>
<segment id="79" parent="1072" relname="joint">and may have a high risk of cancer or neurodegeneration .</segment>
<segment id="80" parent="1081" relname="span">Group III</segment>
<segment id="81" parent="80" relname="elaboration">( &lt;1 % whole population )</segment>
<segment id="82" parent="1082" relname="contrast">represents the ATM -mutated patients with no functional ATM kinase</segment>
<segment id="83" parent="1084" relname="span">or those</segment>
<segment id="84" parent="83" relname="elaboration">who show strong DSB repair defects</segment>
<segment id="85" parent="1086" relname="span">( like the LIG4 -mutated patient</segment>
<segment id="86" parent="85" relname="elaboration">described above ) ,</segment>
<segment id="87" parent="1085" relname="same_unit">hyper-radiosensitivity , and either high cancer proneness or severe accelerated aging .</segment>
<segment id="88" parent="1088" relname="span">While it provides relevant explanation of the radiosensitivity of syndromes</segment>
<segment id="89" parent="88" relname="elaboration">caused by mutations of cytoplasmic proteins ,</segment>
<segment id="90" parent="1089" relname="joint">the RIANS model appears to be compatible with all the alternative models ,</segment>
<segment id="91" parent="1091" relname="span">as ATM is upstream of all the cascades of radiation-induced phosphorylations</segment>
<segment id="92" parent="91" relname="elaboration">involved in the individual response to IR .</segment>
<segment id="93" parent="1092" relname="span">Obviously , further investigations are needed</segment>
<segment id="94" parent="93" relname="purpose">to better understand the direct or indirect role of cytoplasmic ATM forms in the activation or the inhibition of DSB repair pathways .</segment>
<group id="1000" type="span" />
<group id="1001" type="multinuc" parent="1000" relname="span"/>
<group id="1005" type="span" parent="1001" relname="joint"/>
<group id="1006" type="span" parent="1005" relname="span"/>
<group id="1007" type="span" parent="1006" relname="elaboration"/>
<group id="1008" type="span" parent="1007" relname="span"/>
<group id="1009" type="span" parent="1008" relname="elaboration"/>
<group id="1010" type="span" parent="9" relname="circumstance"/>
<group id="1011" type="span" parent="1010" relname="span"/>
<group id="1013" type="span" parent="1001" relname="joint"/>
<group id="1015" type="span" parent="1001" relname="joint"/>
<group id="1016" type="span" parent="15" relname="elaboration"/>
<group id="1020" type="span" parent="1001" relname="joint"/>
<group id="1021" type="multinuc" parent="1020" relname="span"/>
<group id="1022" type="span" parent="1021" relname="same_unit"/>
<group id="1024" type="span" parent="1001" relname="joint"/>
<group id="1025" type="multinuc" parent="1024" relname="span"/>
<group id="1026" type="span" parent="1025" relname="same_unit"/>
<group id="1027" type="span" parent="1025" relname="same_unit"/>
<group id="1028" type="span" parent="1025" relname="elaboration"/>
<group id="1029" type="span" parent="1028" relname="span"/>
<group id="1030" type="span" parent="28" relname="elaboration"/>
<group id="1031" type="span" parent="29" relname="elaboration"/>
<group id="1032" type="span" parent="1001" relname="joint"/>
<group id="1034" type="span" parent="1001" relname="joint"/>
<group id="1035" type="span" parent="1034" relname="span"/>
<group id="1036" type="span" parent="34" relname="elaboration"/>
<group id="1037" type="multinuc" parent="35" relname="elaboration"/>
<group id="1038" type="span" parent="1037" relname="same_unit"/>
<group id="1039" type="span" parent="1035" relname="purpose"/>
<group id="1040" type="span" parent="39" relname="elaboration"/>
<group id="1041" type="span" parent="1040" relname="span"/>
<group id="1042" type="multinuc" parent="1041" relname="circumstance"/>
<group id="1043" type="span" parent="1042" relname="joint"/>
<group id="1044" type="multinuc" parent="1042" relname="joint"/>
<group id="1045" type="span" parent="1044" relname="same_unit"/>
<group id="1046" type="span" parent="1001" relname="joint"/>
<group id="1047" type="span" parent="1046" relname="span"/>
<group id="1048" type="multinuc" parent="1047" relname="span"/>
<group id="1049" type="multinuc" parent="1048" relname="sequence"/>
<group id="1050" type="multinuc" parent="1049" relname="same_unit"/>
<group id="1051" type="span" parent="1050" relname="same_unit"/>
<group id="1052" type="multinuc" parent="1049" relname="same_unit"/>
<group id="1053" type="multinuc" parent="1048" relname="sequence"/>
<group id="1054" type="span" parent="1053" relname="joint"/>
<group id="1055" type="span" parent="1053" relname="joint"/>
<group id="1056" type="span" parent="1057" relname="preparation"/>
<group id="1057" type="multinuc" parent="1055" relname="span"/>
<group id="1059" type="span" parent="1057" relname="joint"/>
<group id="1061" type="span" parent="1057" relname="joint"/>
<group id="1062" type="span" parent="1061" relname="span"/>
<group id="1063" type="span" parent="1062" relname="evidence"/>
<group id="1064" type="span" parent="1057" relname="joint"/>
<group id="1065" type="multinuc" parent="1064" relname="span"/>
<group id="1066" type="span" parent="1065" relname="joint"/>
<group id="1067" type="multinuc" parent="1066" relname="span"/>
<group id="1068" type="multinuc" parent="1067" relname="joint"/>
<group id="1069" type="span" parent="1068" relname="same_unit"/>
<group id="1070" type="span" parent="1068" relname="same_unit"/>
<group id="1071" type="span" parent="1067" relname="joint"/>
<group id="1072" type="multinuc" parent="1071" relname="span"/>
<group id="1073" type="multinuc" parent="1072" relname="joint"/>
<group id="1074" type="span" parent="1073" relname="same_unit"/>
<group id="1075" type="span" parent="1073" relname="same_unit"/>
<group id="1076" type="multinuc" parent="75" relname="elaboration"/>
<group id="1080" type="multinuc" parent="1072" relname="joint"/>
<group id="1081" type="span" parent="1080" relname="same_unit"/>
<group id="1082" type="multinuc" parent="1080" relname="same_unit"/>
<group id="1083" type="span" parent="1082" relname="contrast"/>
<group id="1084" type="span" parent="1083" relname="span"/>
<group id="1085" type="multinuc" parent="1084" relname="elaboration"/>
<group id="1086" type="span" parent="1085" relname="same_unit"/>
<group id="1087" type="span" parent="1072" relname="joint"/>
<group id="1088" type="span" parent="1089" relname="concession"/>
<group id="1089" type="multinuc" parent="1087" relname="span"/>
<group id="1091" type="span" parent="1089" relname="joint"/>
<group id="1092" type="span" parent="1089" relname="joint"/>
	</body>
</rst>
